Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11027512 | PMC |
| http://dx.doi.org/10.1007/s10875-021-00976-x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum to 'Hand grip strength and risk of incident venous thromboembolism: The Tromsø study': [Res Pract Thromb Haemost. 2022 Nov 4;6/7 e12833].
Res Pract Thromb Haemost
October 2024
Thrombosis Research Center (TREC), Department of Clinical Medicine, UiT, The Arctic University of Norway.
[This corrects the article DOI: 10.1002/rth2.12833.
View Article and Find Full Text PDFLong-term immunological changes after corrective cardiac surgery.
Scand J Immunol
December 2024
Department of Pediatrics, Institute of Health Sciences, Division of Pediatric Immunology and Allergy and Master's/Doctoral Program, Jeffrey Modell Primary Immunodeficiency Diagnosis Center, Işıl Barlan Translational Medicine Center, Immunodeficiency Application and Research Center, Faculty of Medicine, Marmara University, Istanbul, Turkey.
Article Synopsis
- * A study involving 22 patients post-thymectomy indicated significant long-term immunological changes, such as lymphopenia, reduced naive T cell counts, and low immunoglobulin levels, pointing to early immune aging.
- * Despite these changes, most patients still showed positive vaccine responses, but the findings suggest a need for preserving thymic tissue during surgery and increased monitoring for immune-related complications over time.
[Newborn screening for severe combined immunodeficiencies (SCID) in Germany].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
November 2023
Pädiatrische Hämatologie und Onkologie, Zentrum für Kinder- und Jugendmedizin und Centrum für Chronische Immundefizienz, Institut für Immundefizienz, Medizinische Fakultät, Universitätsklinikum Freiburg, Freiburg, Deutschland.
Patients with a severe combined immunodeficiency (SCID) harbor genetic mutations disrupting T cell immunity and hence suffer severe, life-threatening infections or manifestations of immune dysregulation within the first months of their life. The only cure is to correct their immune system, usually by means of hematopoietic stem cell transplantation (HSCT). Pilot studies and national programs in the United States and in European countries have shown that patients can be identified at an early asymptomatic stage through newborn screening.
View Article and Find Full Text PDFSystemic immune profile in Prader-Willi syndrome: elevated matrix metalloproteinase and myeloperoxidase and reduced macrophage inhibitory factor.
Orphanet J Rare Dis
July 2023
Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Background: Prader-Willi syndrome (PWS) is a rare genetic neurodevelopmental syndrome with highly increased risk of obesity and cardiovascular disease (CVD). Recent evidence suggests that inflammation is implicated in the pathogenesis. Here we investigated CVD related immune markers to shed light on pathogenetic mechanisms.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!